Skip to main content
. 2015 Mar 25;6(11):9502–9516. doi: 10.18632/oncotarget.3321

Figure 6. Knockdown of TRAIL-R2 in MDA-MB-231-BO cells downregulates the expression of CXCR4 and inhibits migration towards SDF-1.

Figure 6

Control (Ctrl-shRNA) and TRAIL-R2 knockdown cells (R2-shRNA-1 or R2-shRNA-2) were analyzed in regard to their migration capacity towards SDF-1 in a trans-well assay (A). Expression of TRAIL-R1, TRAIL-R2, CXCR4 and EGFR was assessed by flow cytometry on non-permeabilized and permeabilized cells (B) and percent of stained cells (C), as well as staining intensities per cell (D), relative to non-specific antibody controls, were quantified. Graphs represent average values ± SD. (A: n = 4, B-D: n = 3) (*p < 0.05, **p < 0.01 ***p < 0.001).